Intranasal Dexmedetomidine in Children Undergoing Adenotonsillectomy Suffering From Mild Upper Respiratory Tract Infection
NCT ID: NCT05639777
Last Updated: 2022-12-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
70 participants
INTERVENTIONAL
2022-12-06
2023-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intranasal Midazolam for Preanasthetic Sedation for Preschool Children Undergoing Adenotonsillectomy.
NCT07045597
Intranasal Dexmedetomidine, Ketamine or Midazolam for Anxiety and Respiratory Complications in Children
NCT07072117
Transbucal Dexmedetomidine for Prevention of Sevoflurane Emergence Agitation in Pre-school Children
NCT02720705
Oral Dexmedetomidine for Parental Separation in Pediatrics Undergoing Adenotonsillectomy
NCT03551067
Dexmedetomidine in Pediatric Tonsillectomy
NCT01057381
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Upper and lower respiratory infections, as well as asthma, are common in children who are scheduled for adenotonsillectomy. When compared to healthy children, children with respiratory ailments have a three-fold increase in PRAEs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intranasal
That will receive intranasal dexmedetomidine (1.5mcg/kg)
Dexmedetomidine group
That will receive intranasal dexmedetomidine (1.5mcg/kg)
control group
That will receive the same volume of 2 ml of intranasal normal saline
control group
That will receive the same volume of 2 ml of intranasal normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine group
That will receive intranasal dexmedetomidine (1.5mcg/kg)
control group
That will receive the same volume of 2 ml of intranasal normal saline
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. aged from 3 to 10 years
3. ASA Physical Status II,
4. undergoing adenotonsillectomy
Exclusion Criteria
2. Evidence of moderate to severe upper respiratory tract infection at time of presentation on the day of surgery
3. Lower respiratory tract infection
4. Congenital heart diseases
5. Known hypersensitivity to specific anesthetic agent
6. Liver or renal disease
3 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eman Ahmed Azzam
Resident of Anesthesia, Surgical Intensive Care and Pain Mrdicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ayman A Yousef, Professor
Role: PRINCIPAL_INVESTIGATOR
Anesthiology' Surgical Intensive care and Pain Medicine
Gehan M Eid, Professor
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor Anesthiology' Surgical Intensive care and Pain Medicine
Wail E Messbah, Lecturer
Role: PRINCIPAL_INVESTIGATOR
Anesthiology' Surgical Intensive care and Pain Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Eman Ahmed Azzam
Tanta, El-Gharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
35355/3/22
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.